Arnott ID - Search Results

1

An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease.

Arnott ID, McNeill G, Satsangi J. Arnott ID, et al. Aliment Pharmacol Ther. 2003 Jun 15;17(12):1451-7. doi: 10.1046/j.1365-2036.2003.01574.x. Aliment Pharmacol Ther. 2003. PMID: 12823146 Free article.

2

Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury.

Arnott ID, Ghosh S. Arnott ID, et al. Eur J Gastroenterol Hepatol. 2000 May;12(5):569-73. doi: 10.1097/00042737-200012050-00016. Eur J Gastroenterol Hepatol. 2000. PMID: 10833103

3

Administration of infliximab in Crohn's disease does not deplete complement components C3 and C4.

Arnott ID, Shand A, Ghosh S. Arnott ID, et al. Am J Gastroenterol. 2000 Nov;95(11):3326-7. doi: 10.1111/j.1572-0241.2000.03325.x. Am J Gastroenterol. 2000. PMID: 11095380 No abstract available.

4

Abnormal intestinal permeability predicts relapse in inactive Crohn disease.

Arnott ID, Kingstone K, Ghosh S. Arnott ID, et al. Scand J Gastroenterol. 2000 Nov;35(11):1163-9. doi: 10.1080/003655200750056637. Scand J Gastroenterol. 2000. PMID: 11145287

5

Gut mucosal secretion of interleukin 1beta and interleukin-8 predicts relapse in clinically inactive Crohn's disease.

Arnott ID, Drummond HE, Ghosh S. Arnott ID, et al. Dig Dis Sci. 2001 Feb;46(2):402-9. doi: 10.1023/a:1005617302718. Dig Dis Sci. 2001. PMID: 11281191

6

Gut luminal neutrophil migration is influenced by the anatomical site of Crohn's disease.

Arnott ID, Drummond HE, Ghosh S. Arnott ID, et al. Eur J Gastroenterol Hepatol. 2001 Mar;13(3):239-43. doi: 10.1097/00042737-200103000-00004. Eur J Gastroenterol Hepatol. 2001. PMID: 11293442

7

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience.

Arnott ID, McDonald D, Williams A, Ghosh S. Arnott ID, et al. Aliment Pharmacol Ther. 2001 Oct;15(10):1639-46. doi: 10.1046/j.1365-2036.2001.01092.x. Aliment Pharmacol Ther. 2001. PMID: 11564005 Free article. Clinical Trial.

8

Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease.

Arnott ID, Drummond HE, Ghosh S. Arnott ID, et al. Scott Med J. 2001 Oct;46(5):136-9. doi: 10.1177/003693300104600504. Scott Med J. 2001. PMID: 11771492

9

Endoscopic ultrasonography in the diagnosis and management of suspected upper gastrointestinal submucosal tumours.

Shen EF, Arnott ID, Plevris J, Penman ID. Shen EF, et al. Among authors: arnott id. Br J Surg. 2002 Feb;89(2):231-5. doi: 10.1046/j.0007-1323.2001.02002.x. Br J Surg. 2002. PMID: 11856140

10

Successful infliximab treatment for steroid-refractory celiac disease: a case report.

Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, Jackson R, Ghosh S. Gillett HR, et al. Among authors: arnott id. Gastroenterology. 2002 Mar;122(3):800-5. doi: 10.1053/gast.2002.31874. Gastroenterology. 2002. PMID: 11875014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results